Zogenix Is Vastly Over-valued Even With FDA Approval

On Oct 25th, Zogenix, Inc received FDA approval of Zohydro ER extended-release capsules, an opioid agonist, extended-release oral formulation of hydrocodone without acetaminophen.

http://seekingalpha.com/article/1776502-zogenix-is-vastly-over-valued-even-with-fda-approval?source=feed